Adalimumab for Ocular Inflammation

PURPOSE: To evaluate adalimumab as an immunomodulatory treatment for non-infectious ocular inflammatory diseases. METHODS: Characteristics of patients treated with adalimumab were abstracted in a standardized chart review. Main outcomes measured were control of inflammation, corticosteroid-sparing e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ocul Immunol Inflamm
Main Authors: Durrani, Khayyam, Kempen, John H., Ying, Gui-shuang, Kacmaz, R. Oktay, Artornsombudh, Pichaporn, Rosenbaum, James T., Suhler, Eric B., Thorne, Jennifer E., Jabs, Douglas A., Levy-Clarke, Grace A., Nussenblatt, Robert B., Foster, C. Stephen
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033708/
https://ncbi.nlm.nih.gov/pubmed/27003323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09273948.2015.1134581
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki